Avadel Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $50,025 | $41,504 | $27,178 | $19,453 |
Gross Profit | 43,870 | 38,716 | 25,656 | 18,760 |
EBITDA | 1,318 | -11,178 | -24,116 | -26,532 |
EBIT | 283 | -11,615 | -24,657 | -26,514 |
Net Income | -2,625 | -13,822 | -27,342 | -28,786 |
Net Change In Cash | 50,025 | 41,504 | 27,178 | 19,453 |
Free Cash Flow | -6,890 | -18,186 | -29,704 | -28,028 |
Cash | 28,582 | 28,847 | 35,794 | 31,167 |
Basic Shares | 96,300 | 96,151 | 91,693 | 95,019 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $27,963 | $1,496 | $0 | $22,334 |
Gross Profit | 27,117 | -1,493 | -815 | 16,592 |
EBITDA | -149,125 | -97,604 | -84,784 | -34,971 |
EBIT | -150,891 | -99,097 | -85,599 | -36,661 |
Net Income | -160,276 | -137,464 | -77,329 | 7,028 |
Net Change In Cash | 27,963 | 1,496 | 0 | 22,334 |
Cost of Revenue | -20,118 | 61,228 | ||
Free Cash Flow | -128,511 | -71,020 | -77,336 | -48,832 |
Cash | 31,167 | 73,981 | 50,708 | 71,722 |
Basic Shares | 80,174 | 60,094 | 58,535 | 54,941 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.02 |
2024-06-30 | -$0.14 |
2024-03-31 | -$0.30 |
2023-12-31 | -$0.29 |
